Broken String Biosciences
PrivateLast Round
Series A
Sep 18, 2023
Total Funding Raised
$19M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Broken String Biosciences is a biotechnology company that develops a sequencing platform to enhance the safety and efficacy of cell and gene therapies through advanced sequencing techniques, bioinformatics, and artificial intelligence.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Biotech Equipment
Business Model
B2B
Customer Profile
Services & Consulting, Usage-Based SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Broken String Biosciences Comparables
Compare Broken String Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Countagen AB | 80% | |
| Zhuhai Shutong Medical Technology Co., Ltd. | 78% | |
| MaxCyte Inc | 77% |
Broken String Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Sep 18, 2023 | ||||
| Seed | Jan 21, 2022 | ||||
| Accelerator | Feb 8, 2021 |
Key People
Founding team and executive leadership
Broken String Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Dieter von Holtzbrinck Ventures | Series A, Seed |
| Korys | Series A |
| HERAN Partners | Series A |
| Time Boost Capital I LP | Seed |
| Merieux Developement | Series A |
| First In Ventures | Seed |
| Mérieux Equity Partners | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors increased 1039% to 5K.
- May 21, 2026
Monthly visitors increased 38% MoM.
Recent news
Latest coverage and updates
- expands_facilitiesSep 10, 2026
Broken String Biosciences expands its laboratory space in Essex.
- launchesAug 10, 2026
Broken String Biosciences launches BaseMap(TM) ABE in United Kingdom on Aug 10th '26, enabling genome-wide off-target characterization for adenine base editing applications and offering researchers early access through its Early Access Program.
Broken String Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Broken String Biosciences's valuation, stock price, and market status.
Is Broken String Biosciences a public or private company?
Broken String Biosciences is a private company.
What is the current stock price of Broken String Biosciences?
Broken String Biosciences is a private company, so its shares have no public market price. Caplight tracks Broken String Biosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Broken String Biosciences worth (valuation)?
Valuation information for Broken String Biosciences is not publicly available.
Can I buy Broken String Biosciences stock?
Broken String Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Broken String Biosciences's last funding round?
Broken String Biosciences's most recent funding round was Series A on September 18, 2023.
Who are the main investors in Broken String Biosciences?
Key investors in Broken String Biosciences include Dieter von Holtzbrinck Ventures, Merieux Developement, Mérieux Equity Partners, Illumina Accelerator, Illumina Ventures.
Will Broken String Biosciences IPO soon?
No public IPO plans have been announced for Broken String Biosciences.
How can I track Broken String Biosciences secondary market activity?
Caplight tracks bids, offers, and trades in Broken String Biosciences's shares on secondary markets.